Evidence map›Paper›PMID 41916302›Full record

ArticleCell reports methods2026

Benchmarking RNA velocity methods across 17 independent studies.

Ya Luo, Jun Ren, Qian Yang, Zhiyu You, Ying Zhou, Qingqing Qin, Qiyuan Li

Abstract read
In one paragraph

Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ya LuoDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Jun RenDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Qian YangDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Zhiyu YouNational Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Ying ZhouNational Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Qingqing QinNational Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China.
Qiyuan LiDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China; National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Fujian 361102, China. Electronic address: qiyuan.li@xmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA velocity techniques offer great potential for unveiling trajectories of cell state transitions in different biological contexts. While diverse computational methods have been developed, there are no evidence-based guidelines for best-practice in RNA velocity inference. Here, we conduct a benchmark study of 15 existing RNA velocity methods across 17 independent datasets, incorporating multiple validation strategies. We evaluate performance across three key dimensions: accuracy, stability, and usability. Our data showed no single method exhibited superior performance in all the assessments, and unexpected underperformance was observed in certain cases. Based on these findings, we establish scenario-based suggestions of best-practice to assist users in selecting the method best suited to their data and analytical needs.

Indexed as

BenchmarkingComputational BiologyRNAHumansRNAcell evolutionary dynamicsCP: computational biologyCP: systems biologyRNA velocityscRNA-seq

Identifiers

PMID41916302
PMCPMC13106975

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.